Longboard Pharmaceuticals Receives Breakthrough Therapy Designation for Bexicaserin (LP352)
Longboard藥品因貝西卡塞林(LP352)獲得突破性療法認定
Longboard Pharmaceuticals Receives Breakthrough Therapy Designation for Bexicaserin (LP352)
Longboard藥品因貝西卡塞林(LP352)獲得突破性療法認定
譯文內容由第三人軟體翻譯。